Association between high-density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization.

atypical atrial flutter healthcare utilization high density mapping

Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
04 Jul 2024
Historique:
revised: 07 06 2024
received: 19 02 2024
accepted: 20 06 2024
medline: 5 7 2024
pubmed: 5 7 2024
entrez: 5 7 2024
Statut: aheadofprint

Résumé

Success of atypical atrial flutter (AAFL) ablation has historically been limited by difficulty mapping the complex re-entrant circuits involved. While high-density (HD) mapping has become commonplace in clinical practice, there are limited data on outcomes of HD versus non-HD mapping for AAFL ablation. To compare clinical outcomes and healthcare utilization using HD mapping versus non-HD mapping for AAFL ablation. Retrospective analysis of all AAFL procedures between 2005 and 2022 at an academic medical center was conducted. Procedures utilizing a 16-electrode HD Grid catheter and Precision mapping system were compared to procedures using prior generation 10-20 electrode spiral catheters and the Velocity system (Abbott, IL). Cox regression models and Poisson regression models were utilized to examine procedural and healthcare utilization outcomes. Models were adjusted for left ventricular ejection fraction, CHA There were 108 patients (62% HD mapping) included in the analysis. Baseline clinical characteristics were similar between groups. Use of HD mapping was associated with a higher rate of AAFL circuit delineation (92.5% vs. 76%; p = .014) and a greater adjusted procedure success rate, defined as non-inducibility at procedure end, (aRR (95% CI) 1.26 (1.02-1.55) p = .035) than non-HD mapping. HD mapping was also associated with a lower rate of ED visits (aIRR (95% CI) 0.32 (0.14-0.71); p = .007) and hospitalizations (aIRR (95% CI) 0.32 (0.14-0.68); p = .004) for AF/AFL/HF through 1 year. While there was a lower rate of recurrent AFL through 1 year among HD mapping cases (aHR (95% CI) 0.60 (0.31-1.16) p = .13), statistical significance was not met likely due to the low sample size and higher rate of ambulatory rhythm monitoring in the HD group (61% vs. 39%, p = .025). Compared to non-HD mapping, AAFL ablation with HD mapping is associated with improvements in the ability to define the AAFL circuit, greater procedural success, and a reduction in the number of ED visits and hospitalization for AF/AFL/HF.

Sections du résumé

BACKGROUND BACKGROUND
Success of atypical atrial flutter (AAFL) ablation has historically been limited by difficulty mapping the complex re-entrant circuits involved. While high-density (HD) mapping has become commonplace in clinical practice, there are limited data on outcomes of HD versus non-HD mapping for AAFL ablation.
OBJECTIVE OBJECTIVE
To compare clinical outcomes and healthcare utilization using HD mapping versus non-HD mapping for AAFL ablation.
METHODS METHODS
Retrospective analysis of all AAFL procedures between 2005 and 2022 at an academic medical center was conducted. Procedures utilizing a 16-electrode HD Grid catheter and Precision mapping system were compared to procedures using prior generation 10-20 electrode spiral catheters and the Velocity system (Abbott, IL). Cox regression models and Poisson regression models were utilized to examine procedural and healthcare utilization outcomes. Models were adjusted for left ventricular ejection fraction, CHA
RESULTS RESULTS
There were 108 patients (62% HD mapping) included in the analysis. Baseline clinical characteristics were similar between groups. Use of HD mapping was associated with a higher rate of AAFL circuit delineation (92.5% vs. 76%; p = .014) and a greater adjusted procedure success rate, defined as non-inducibility at procedure end, (aRR (95% CI) 1.26 (1.02-1.55) p = .035) than non-HD mapping. HD mapping was also associated with a lower rate of ED visits (aIRR (95% CI) 0.32 (0.14-0.71); p = .007) and hospitalizations (aIRR (95% CI) 0.32 (0.14-0.68); p = .004) for AF/AFL/HF through 1 year. While there was a lower rate of recurrent AFL through 1 year among HD mapping cases (aHR (95% CI) 0.60 (0.31-1.16) p = .13), statistical significance was not met likely due to the low sample size and higher rate of ambulatory rhythm monitoring in the HD group (61% vs. 39%, p = .025).
CONCLUSION CONCLUSIONS
Compared to non-HD mapping, AAFL ablation with HD mapping is associated with improvements in the ability to define the AAFL circuit, greater procedural success, and a reduction in the number of ED visits and hospitalization for AF/AFL/HF.

Identifiants

pubmed: 38965878
doi: 10.1111/jce.16355
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.

Références

Ko Ko NL, Sriramoju A, Khetarpal BK, Srivathsan K. Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes. Curr Opin Cardiol. 2022;37(1):36‐45. doi:10.1097/hco.0000000000000924
Garan H. Atypical atrial flutter. Heart Rhythm. 2008;5(4):618‐621. doi:10.1016/j.hrthm.2007.10.031
Wasmer K, Mönnig G, Bittner A, et al. Incidence, characteristics, and outcome of left atrial tachycardias after circumferential antral ablation of atrial fibrillation. Heart Rhythm. 2012;9(10):1660‐1666. doi:10.1016/j.hrthm.2012.06.007
Cosío FG. Atrial flutter, typical and atypical: a review. Arrhythm Electrophysiol Rev. 2017;6(2):55‐62. doi:10.15420/aer.2017.5.2
Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. J Am Coll Cardiol. 2016;67(13):e27‐e115. doi:10.1016/j.jacc.2015.08.856
Masuda M, Asai M, Iida O, et al. Left atrial voltage mapping with a direction‐independent grid catheter: comparison with a conventional circular mapping catheter. J Cardiovasc Electrophysiol. 2019;30(12):2834‐2840. doi:10.1111/jce.14263
Fiedler L, Roca I, Lorgat F, et al. Characterization of high‐density mapping in catheter ablation for persistent atrial fibrillation: results from the Advisor™ HD grid mapping catheter observational study. J Interv Card Electrophysiol. 2023;66(6):1411‐1421. doi:10.1007/s10840-022-01442-3
Lakkireddy D. High power ultra short duration ablation with HD grid improves freedom from atrial fibrillation and redo procedures compared to circular mapping catheter. J Atr Fibrillation. 2020;13(2):2414. doi:10.4022/jafib.2414
Deno DC, Bhaskaran A, Morgan DJ, et al. High‐resolution, live, directional mapping. Heart Rhythm. 2020;17(9):1621‐1628. doi:10.1016/j.hrthm.2020.04.039
Raymond‐Paquin A, Pillai A, Myadam R, et al. Atypical atrial flutter catheter ablation in the era of high‐density mapping. J Interv Card Electrophysiol. 2023;66(8):1807‐1815. doi:10.1007/s10840-023-01475-2
Balt JC, Klaver MN, Mahmoodi BK, van Dijk VF, Wijffels MCEF, Boersma LVA. High‐density versus low‐density mapping in ablation of atypical atrial flutter. J Interv Card Electrophysiol. 2021;62(3):587‐599. doi:10.1007/s10840-021-00939-7
Di Cori A, Mazzocchetti L, Parollo M, et al. Clinical impact of high‐density mapping on the acute and long term outcome of atypical atrial flutter ablations. J Interv Card Electrophysiol. 2024;67(1):43‐51. doi:10.1007/s10840-022-01121-3
Charitos EI, Stierle U, Ziegler PD, et al. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation. 2012;126(7):806‐814. doi:10.1161/circulationaha.112.098079

Auteurs

Joshua Sink (J)

Department of Internal Medicine, Northwestern University, Chicago, Illinois, USA.

Kasen Culler (K)

Department of Internal Medicine, Northwestern University, Chicago, Illinois, USA.

Lakshmi Uppalapati (L)

Department of Internal Medicine, Baylor University, Houston, Texas, USA.

Nicola Lancki (N)

Department of Preventative Medicine, Northwestern University, Chicago, Illinois, USA.

Graham Peigh (G)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Graham Lohrmann (G)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Mahmoud Elsayed (M)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Herman Carneiro (H)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Jayson Baman (J)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Anna Pfenniger (A)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Kaustubha D Patil (KD)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Nishant Verma (N)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Rishi Arora (R)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Susan S Kim (SS)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Alexandru B Chicos (AB)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Albert C Lin (AC)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Bradley P Knight (BP)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Rod S Passman (RS)

Division of Cardiology, Northwestern University, Chicago, Illinois, USA.

Classifications MeSH